Katharine Cioe, MD
Psychiatry ResidentDownloadHi-Res Photo
About
Copy Link
Titles
Psychiatry Resident
Biography
Dr. Katharine Cioe completed her undergraduate degree at the University of Connecticut. She received her medical degree at the Frank H. Netter School of Medicine at Quinnipiac University, where she was elected to the Gold Humanism Honor Society. Dr. Cioe completed the first three years of her residency at Northwell Zucker Hillside Hospital on the research track. She is currently the chief resident of the Interventional Psychiatry Service at Yale. She is also the president of the Interventional Psychiatry residency interest group.
Last Updated on August 23, 2025.
Departments & Organizations
Education & Training
- Psychiatry Resident
- Northwell Zucker Hillside Hospital (2025)
- MD
- Frank H. Netter School of Medicine (2021)
Research
Copy Link
Overview
Medical Research Interests
Depressive Disorder, Treatment-Resistant; Electroconvulsive Therapy; Ketamine; Mood Disorders; Parkinson Disease; Schizophrenia
Research at a Glance
Yale Co-Authors
Frequent collaborators of Katharine Cioe's published research.
Sandra Ann Springer, MD
Publications
2020
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder
Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder. Journal Of Substance Use And Addiction Treatment 2020, 119: 108146. PMID: 33138929, PMCID: PMC7609980, DOI: 10.1016/j.jsat.2020.108146.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsOpioid use disorderOpioid epidemicProvider perspectivesUse disordersSystematic reviewType of MOUDExtended-release naltrexoneNumber of patientsOutcomes of interestPubMed database searchReview eligibility criteriaPatient themesPublic health crisisPatient retentionMOUDEligibility criteriaPatientsProviders' perceptionsFinal reviewLack of trainingMedicationsBuprenorphineNaltrexoneMethadoneHealth crisis